Metformin (1,1-dimethylbiguanide), an insulin-sensitizer, is currently a basis drug used in the treatment of T2DM recommended in all stages of therapy, in monotherapy and in combination with other oral antihyperglycemic drugs and insulin [9,10,11]. This evidence concerns the gene INS and type 2 diabetes mellitus.